ANESTHESIA FOR THE AGED - SOME PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS

被引：0

|

作者：

MILLER, R

机构：

来源：

MOUNT SINAI JOURNAL OF MEDICINE | 1987年 / 54卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：305 / 307

页数：3

相关论文

共 50 条

[31] The importance of appropriate antimicrobial dosing: Pharmacokinetic and pharmacodynamic considerations
Preston, SL
ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : S14 - S18
[32] Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations
Shen, Jie
Lu, Guang Wei
Hughes, Patrick
PHARMACEUTICAL RESEARCH, 2018, 35 (11)
[33] Optimizing the use of erythropoietic agents - pharmacokinetic and pharmacodynamic considerations
Macdougall, IC
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 : 66 - 70
[34] The maximum pharmacodynamic effect as a response parameter: Pharmacokinetic considerations
Leopold, CS
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (09) : 999 - 1008
[35] Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics
Shah, Dhaval K.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 (05) : 553 - 571
[36] Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Severe Infections EDITORIAL
Bellmann, Romuald
CURRENT CLINICAL PHARMACOLOGY, 2013, 8 (01): : 3 - 4
[37] Antimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic–Pharmacodynamic Considerations
Tiphaine Goulenok
Bruno Fantin
Clinical Pharmacokinetics, 2013, 52 : 869 - 883
[38] Antibiotic Pharmacokinetic and Pharmacodynamic Considerations in Patients With Kidney Disease
Eyler, Rachel F.
Mueller, Bruce A.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (05) : 392 - 403
[39] Pharmacokinetic/pharmacodynamic considerations for cancer patients undergoing hemodialysis
Janus, Nicolas
Launay-Vacher, Vincent
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (06) : 617 - 623
[40] Penetration of Antibacterials into Bone Pharmacokinetic, Pharmacodynamic and Bioanalytical Considerations
Landersdorfer, Cornelia B.
Bulitta, Juergen B.
Kinzig, Martina
Holzgrabe, Ulrike
Soergel, Fritz
CLINICAL PHARMACOKINETICS, 2009, 48 (02) : 89 - 124

← 1 2 3 4 5 →